维普中文期刊产品整合服务
43篇 您的检索式:作者名="KARIHTALA P"
    题名 作者 年代 出处 被引量
1Peroxiredoxins in breast carcinoma显示文摘Karihtala P Mantyniemi A Kang SW 2003Clin Cancer Res2003,9,9:1
2Reactive Oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies 显示文摘Karihtala P Soini Y 2007APMIS2007,115,2:1
3Thioredoxin is associated with proliferation,p53 expression and negative estrogen and progesterone receptor status in breast carcinoma显示文摘TURUNEN N KARIHTALA P MANTYNIEMI A 2004APMIS2004,112,:1
4Vimentin, zebl and Sipl are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phe- notype 显示文摘Karihtala P Auvinen P Kauppila S 2013Breast Cancer Res Treat2013,138,1:1
5Vimentin, zebl and Sipl are up-regulated in triple-negative and bas- al-like breast cancers: association with an aggressive tumour phenotype 显示文摘Karihtala P Auvinen P Kauppila S 2013Breast Cancer Res Treat2013,138,1:1
6Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies显示文摘Karihtala P Soini Y 0,,:1
7Divergent be- haviour of oxidative stress markers 8 hydroxyde oxyguanosine ( 8-OHdG ) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis显示文摘Karihtala P Kauppila S Puistola U 2011Histopathology2011,58,6:1
8Tumor infiltrating CD8 +T lymphocyte count is independent of tumor TLR9 status in treatment naive triple negative breast cancer and renal cell carci- noma显示文摘Mella M Kauppila JH Karihtala P 2015Oncoimmnnology2015,4,6:1
9Peroxiredoxins in breast carcinoma显示文摘Karihtala P Mantyniemi A Kang SW 2003Clin Cancer Res2003,9,9:1
10Peroxiredoxins in breast carcinoma显示文摘Karihtala P M/intyniemi A Kang SW 2003Clin Cancer Res2003,9,9:1
11Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma显示文摘Turunen N Karihtala P Mantyniemi A 2004APMIS2004,112,2:1
12Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies 显示文摘Karihtala P Soini Y 2007APM IS2007,115,2:1
13Peroxiredoxins in breast carcinoma 显示文摘Karihtala P Mantyniemi A Kang SW 2003Clin Cancer Res2003,9,9:1
14Front-line bevacizumab in serous epithelial ovarian cancer:biomarker analysis of the FINAVAST trial显示文摘Karihtala P Maenpaa J Turpeenniemi-Hujanen T 2010Anticancer Res2010,30,3:1
15Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma 显示文摘Turunen N Karihtala P Mantyniemi A 2004A PM IS2004,112,:1
16Biological roles and prognostic values of the epithelial-mesenchym J transitionediating transcription factom Twist,ZEBl and slug in diffusearge B-cell lymphoma显示文摘Lemma S Karihtala P Haapasaafi KM et a1 2013Histopathology2013,62,2:1
17Vimentin, zebl and sipl are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive turnout phenotype显示文摘Karihtala P Auvinen P Kauppila S 2013Breast Cancer Res Treat2013,138,1:1
18Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma显示文摘Turunen N Karihtala P Mantyniemi A 2004APMIS2004,112,:1
19Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma 显示文摘Turunen N Karihtala P Mantyniemi A 2004APMIS2004,112,2:1
20Vimentin, zebl and Sipl are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype 显示文摘Karihtala P Auvinen P Kauppila S 2013Breast Cancer Res Treat2013,138,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费